Greenrose Acquisition Corp Stock Cash And Equivalents
| GNRSDelisted Stock | USD 0.28 0.05 21.74% |
Greenrose Acquisition Corp fundamentals help investors to digest information that contributes to Greenrose Acquisition's financial success or failures. It also enables traders to predict the movement of Greenrose OTC Stock. The fundamental analysis module provides a way to measure Greenrose Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Greenrose Acquisition otc stock.
Greenrose |
Greenrose Acquisition Corp OTC Stock Cash And Equivalents Analysis
Greenrose Acquisition's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Greenrose Acquisition Cash And Equivalents | 1.61 M |
Most of Greenrose Acquisition's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Greenrose Acquisition Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Greenrose Acquisition Corp has 1.61 M in Cash And Equivalents. This is 99.8% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The cash and equivalents for all United States stocks is 99.94% higher than that of the company.
Greenrose Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Greenrose Acquisition's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Greenrose Acquisition could also be used in its relative valuation, which is a method of valuing Greenrose Acquisition by comparing valuation metrics of similar companies.Greenrose Acquisition is currently under evaluation in cash and equivalents category among its peers.
Greenrose Fundamentals
| Return On Equity | 0.35 | |||
| Return On Asset | -0.15 | |||
| Profit Margin | 0.47 % | |||
| Operating Margin | (1.46) % | |||
| Current Valuation | 147.92 M | |||
| Shares Outstanding | 17.68 M | |||
| Shares Owned By Insiders | 71.75 % | |||
| Shares Owned By Institutions | 15.15 % | |||
| Number Of Shares Shorted | 290.74 K | |||
| Price To Earning | 0.57 X | |||
| Price To Book | 0.48 X | |||
| Price To Sales | 0.25 X | |||
| Revenue | 28.4 M | |||
| Gross Profit | 18.68 M | |||
| EBITDA | (11.53 M) | |||
| Net Income | 83.3 M | |||
| Cash And Equivalents | 1.61 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 119.81 M | |||
| Debt To Equity | 2.38 % | |||
| Current Ratio | 0.15 X | |||
| Book Value Per Share | 0.82 X | |||
| Cash Flow From Operations | (47.71 M) | |||
| Short Ratio | 2.80 X | |||
| Earnings Per Share | 3.10 X | |||
| Number Of Employees | 91 | |||
| Beta | 0.32 | |||
| Market Capitalization | 12.2 M | |||
| Total Asset | 239.09 M | |||
| Net Asset | 239.09 M |
About Greenrose Acquisition Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Greenrose Acquisition Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Greenrose Acquisition using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Greenrose Acquisition Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Greenrose OTC Stock
If you are still planning to invest in Greenrose Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenrose Acquisition's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |